| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 44.34B | 47.63B | 42.13B | 39.16B | 36.94B | 34.08B |
| Gross Profit | 26.34B | 15.18B | 24.78B | 21.96B | 20.20B | 17.45B |
| EBITDA | 9.46B | 9.66B | 8.79B | 7.12B | 6.17B | 5.87B |
| Net Income | 4.12B | 3.89B | 3.59B | 2.13B | 2.27B | 2.14B |
Balance Sheet | ||||||
| Total Assets | 44.60B | 49.00B | 40.05B | 38.09B | 36.30B | 32.93B |
| Cash, Cash Equivalents and Short-Term Investments | 2.75B | 2.14B | 2.22B | 2.01B | 2.54B | 1.87B |
| Total Debt | 8.50B | 9.63B | 8.03B | 9.12B | 8.89B | 7.67B |
| Total Liabilities | 18.28B | 20.33B | 16.47B | 17.18B | 16.38B | 14.35B |
| Stockholders Equity | 26.24B | 28.58B | 23.55B | 20.91B | 19.89B | 18.25B |
Cash Flow | ||||||
| Free Cash Flow | 1.28B | 1.46B | 4.32B | 2.12B | 2.15B | 362.00M |
| Operating Cash Flow | 2.96B | 6.27B | 7.95B | 5.87B | 6.02B | 3.12B |
| Investing Cash Flow | -1.49B | -4.58B | -3.76B | -3.44B | -3.89B | -2.64B |
| Financing Cash Flow | -1.36B | -1.73B | -4.31B | -2.63B | -1.38B | -954.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹205.71B | 86.29 | ― | 0.23% | 45.16% | 36.74% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
64 Neutral | ₹68.59B | 17.56 | ― | 2.32% | 13.05% | 7.99% | |
61 Neutral | ₹70.10B | 54.47 | ― | ― | 5.25% | ― | |
54 Neutral | ₹52.90B | 100.69 | ― | ― | -8.91% | -76.31% | |
50 Neutral | ₹85.68B | 13.86 | ― | ― | 15.56% | -63.16% | |
47 Neutral | ₹43.87B | -14.16 | ― | ― | 19.77% | -479.97% |